Diagnostic Criteria for Strongyloidiasis
Diagnostic Methods
- The American Gastroenterological Association recommends the use of serological tests, such as enzyme-linked immunosorbent assay (ELISA) and immunoblot, as the primary diagnostic method for strongyloidiasis, due to the low sensitivity of a single stool examination 1
- The use of ELISA tests with crude antigens should be avoided due to their low sensitivity and specificity 1
- The diagnosis of strongyloidiasis is often made through serological tests, especially when stool examinations are negative, with a sensitivity of over 80% for the detection of eggs, cysts, and parasites, but lower for Strongyloides 2, 3
- The European Society of Clinical Microbiology and Infectious Diseases recommends the use of microscopic examination of stool samples, with a sensitivity of over 80% for the detection of eggs, cysts, and parasites, but lower for Strongyloides 2
Evaluation and Treatment
- The Infectious Diseases Society of America recommends a complete blood count to identify eosinophilia, which is common in Strongyloides infections, with a sensitivity of over 80% 2, 3
- The treatment of strongyloidiasis with ivermectin is recommended, with a dose of 200 μg/kg orally for 2 consecutive days, and a regimen of ivermectin 200 μg/kg on days 1, 2, 15, and 16 for immunocompromised patients 4
- The Centers for Disease Control and Prevention recommend avoiding the initiation of corticosteroid therapy without first treating strongyloidiasis, as this can precipitate a potentially fatal hyperinfection syndrome 4
Strongyloides Infection Treatment Guidelines
Diagnosis and Evaluation
- The pulmonary strongyloidiasis (Löeffler's syndrome) results from larval migration through the lungs after an acute helminthic infection, mainly by nematodes such as Strongyloides spp., with clinical presentation including fever, urticaria, wheezing, dry cough, and rarely hemoptysis, and can be diagnosed with radiographic findings of migratory pulmonary infiltrates 5, 6
- The diagnosis can be supported by the presence of larvae in sputum or bronchoalveolar lavage, although this is rare, and the clinical context of the patient, including exposure history and symptoms 5
- The use of corticosteroids can lead to hyperinfection in strongyloidiasis, emphasizing the need for caution in patients with this condition [5, ignore ref]
Treatment Approach
- In cases where the specific organism is not identified, empirical treatment with a single dose of ivermectin 200 μg/kg plus albendazol 400 mg may be considered, based on the patient's clinical presentation and risk factors 5
Prevention and Screening
- The Infectious Diseases Society of America recommends screening for Strongyloides stercoralis in patients who will likely require prolonged corticosteroid use, to prevent hyperinfection syndrome 7
- Repeat treatment one month after resolution of pulmonary symptoms may be necessary to ensure that adult worms are treated, as part of a comprehensive treatment plan 5
ELISA Testing for Strongyloides: Diagnostic Approach
Primary Recommendation
- The Journal of Crohn's and Colitis recommends serological testing with ELISA using recombinant antigens as the primary diagnostic method for strongyloidiasis, particularly in patients with travel history to endemic regions or those who are immunocompromised, with sensitivity exceeding 80% for detection compared to stool microscopy 8
Diagnostic Algorithm
First-Line Testing
- The Journal of Crohn's and Colitis recommends obtaining serological ELISA testing as the primary diagnostic method, with sensitivity exceeding 80% for detection compared to stool microscopy which has poor sensitivity for Strongyloides specifically 8
- The Journal of Crohn's and Colitis suggests performing stool microscopy using concentration techniques on multiple samples, though sensitivity remains limited even with three specimens 8
- Consider immunofluorescence or enzyme immunoassay for specific parasites if initial testing is inconclusive 8
High-Risk Populations Requiring Screening
Mandatory Screening Indications
- The Journal of Crohn's and Colitis recommends mandatory screening for long-term travelers (>1 month) returning from endemic areas 8
- The Journal of Crohn's and Colitis recommends screening for immunocompromised patients, including those with IBD on immunomodulators, hematologic malignancies, or chemotherapy 8
Critical Clinical Pitfalls
Timing Considerations
- The Journal of Crohn's and Colitis recommends repeat testing 8-10 weeks after return from endemic areas if initial screening was negative before travel 8
Diagnostic Approach for Strongyloides Infection
Diagnostic Testing
- Elevated total serum IgE is a nonspecific finding present in 59% of strongyloidiasis cases, but is not diagnostically reliable as it occurs in many allergic and parasitic conditions 9